Word-Retrieval Treatment for Aphasia: Semantic Feature Analysis
Study Details
Study Description
Brief Summary
The purpose of this investigation is to further develop and test a treatment for word-finding problems in aphasia. The treatment is designed to strengthen meaning associations within categories of words (e.g., animals, tools, fruits). The treatment is also designed to be used as a search strategy in instances of word-finding difficulty. The study was devised to evaluate the extent to which treatment increases the ability to recall trained, as well as untrained, words.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
The purpose of the proposed research is to examine the effects of a semantically-oriented treatment on word retrieval in persons with aphasia. The planned investigations are designed to further the development of semantic feature training so that it may serve as not only a mechanism for improving disrupted lexical semantic processing, but also as a compensatory strategy during word retrieval failures. The proposed research will also address the issue of exemplar typicality (Kiran & Thompson, 2003) by examining the effects of training typical versus atypical exemplars of various categories with individuals with different types of aphasia. A series of 24 single subject experimental designs will be conducted in the context of a group design to address the following experimental questions:
-
Will training atypical examples of living and artifact noun categories using semantic feature training result in a significantly different outcome* than training typical examples of living and artifact noun categories?
-
Will training of one category of nouns using semantic feature training result in improved retrieval of untrained categories of nouns?
-
Will effects of semantic feature training vary across aphasia types?
-
Will semantic feature training result in increased production of content during discourse?
-
Will generalization to untrained typical examples vary across generalization lists that are repeatedly exposed and those that are limited in exposure? (i.e., Does repeated exposure appear to contribute to generalization?)
-
Outcome measure will reflect acquisition, response generalization within category, and response generalization across category effects of treatment.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Semantic Feature Analysis (SFA) Word retrieval treatment for aphasia. |
Behavioral: Semantic Feature Analysis (SFA)Training
SFA entails having the speech-language pathologist (SLP) guide the participant through generation of pertinent semantic features for pictured treatment items (e.g., category membership, physical description, location of item in context, personal associations, action associated with item). For some participants, treatment items were grouped according to typicality of category membership (e.g,, a robin-typical bird and penguin-atypical bird). Training of atypical items may stimulate a broader semantic activation of the category and thus, may promote greater generalization. Treatment was applied sequentially to sets of items in the context of single-subject, multiple baseline designs. In this way, replication of treatment effects could be evaluated within and across participants. Treatment was administered by certified SLPs three times per week until prescribed accuracy levels were met during nontreatment probes or a maximum number of treatment sessions was completed.
|
No Intervention: Participants for Stimuli Development Non-brain-injured participants provided data for development of treatment stimuli. |
Outcome Measures
Primary Outcome Measures
- Word Retrieval Accuracy [End of treatment and at 6 weeks post treatment]
Accuracy of naming of pictured treated and untreated items was assessed in probes conducted separate from treatment. Probes were conducted repeatedly throughout the study, from baseline (prior to treatment) to follow-up (6 weeks following treatment). All naming responses were scored using a 0-10 scale reflecting promptness and presence of errors; scores of 8-10 received an "accuate" score and scores of 0-7 received an "inaccurate" score. A percentage accuracy score was calculated for each experimental set of items for every probe session. Baseline probe scores were compared to end of treatment and follow-up probe scores to obtain individual effect sizes for each experimental list of items for each participant (i.e., several effect sizes were calculated for each participant). All effect sizes were utlized to obtain an average effect size for each participant; these averages were then utlized to obtain a group average.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Diagnosis of Wernicke's, Broca's, or Conduction aphasia with significant word-retrieval deficits
-
At least 6 months post-onset of single, left-hemisphere stroke
-
Minimum of high-school education
-
Visual and auditory acuity sufficient for experimental tasks
-
Nonverbal intelligence within normal limits
Exclusion Criteria:
-
Diagnosed mental illness other than depression
-
Neurological condition other than that which resulted in aphasia
-
History of alcohol or substance abuse
-
Non-native English speaker
-
Premorbid history of speech/language disorder
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | VA Salt Lake City Health Care System, Salt Lake City | Salt Lake City | Utah | United States | 84148 |
Sponsors and Collaborators
- US Department of Veterans Affairs
Investigators
- Principal Investigator: Julie L. Wambaugh, PhD, VA Salt Lake City Health Care System, Salt Lake City
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- C3826-R
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | Non Treatment Stimuli Development Participants | SFA Treatment Participants |
---|---|---|
Arm/Group Description | Non-brain-injured participants who were enrolled for the purpose of stimuli development | Stroke survivors who received experimental therapy |
Period Title: Overall Study | ||
STARTED | 94 | 16 |
COMPLETED | 87 | 14 |
NOT COMPLETED | 7 | 2 |
Baseline Characteristics
Arm/Group Title | SFA Treatment Participants | Non Treatment Stimuli Development Participants | Total |
---|---|---|---|
Arm/Group Description | Semantic Feature Analysis (SFA) is a word-retrieval treatment for aphasia. SFA entails having the speech-language pathologist (SLP) guide the participant through generation of pertinent semantic features for pictured treatment items (e.g., category membership, physical description, location of item in context, personal associations, associated actions). For some participants, treatment items were grouped by typicality of category membership (e.g, robin-typical bird and penguin-atypical bird). Training of atypical items may stimulate a broader semantic activation of the category and thus, may promote greater generalization. Treatment was applied sequentially to sets of items in single-subject, multiple baseline designs. Thus, replication of treatment effects could be evaluated within and across participants. Treatment was administered by SLPs three times per week until prescribed accuracy levels were met during probes or a maximum number of treatment sessions was completed. | Participants for stimuli development provided normative data for stimuli development. e.g., Treatment items were grouped according to typicality of category membership (apple - typical fruit; coconut - atypical fruit). These participants provided the reponses that served as the basis for classifying/organizing stimuli. Because data from this group were used only for the purposes of stimuli development, no findings are reported for this group. See Cameron, R.M., Wambaugh, J.L., & Mauszycki, S. (2008). Effects of age, gender and education on semantic fluency for living and artifact categories. Aphasiology, 22(7/8), 790-801, doi: 10.1080/02687030701818018 for related findings. | Total of all reporting groups |
Overall Participants | 16 | 94 | 110 |
Age, Customized (participants) [Number] | |||
21-80 Years |
16
100%
|
94
100%
|
110
100%
|
Sex: Female, Male (Count of Participants) | |||
Female |
4
25%
|
47
50%
|
51
46.4%
|
Male |
12
75%
|
47
50%
|
59
53.6%
|
Outcome Measures
Title | Word Retrieval Accuracy |
---|---|
Description | Accuracy of naming of pictured treated and untreated items was assessed in probes conducted separate from treatment. Probes were conducted repeatedly throughout the study, from baseline (prior to treatment) to follow-up (6 weeks following treatment). All naming responses were scored using a 0-10 scale reflecting promptness and presence of errors; scores of 8-10 received an "accuate" score and scores of 0-7 received an "inaccurate" score. A percentage accuracy score was calculated for each experimental set of items for every probe session. Baseline probe scores were compared to end of treatment and follow-up probe scores to obtain individual effect sizes for each experimental list of items for each participant (i.e., several effect sizes were calculated for each participant). All effect sizes were utlized to obtain an average effect size for each participant; these averages were then utlized to obtain a group average. |
Time Frame | End of treatment and at 6 weeks post treatment |
Outcome Measure Data
Analysis Population Description |
---|
SFA Treatment Participants were stroke-survivors with chronic aphasia who had significant word retrieval difficulties. Non Treatment Stimuli Development Participants were only enrolled in the study to provide data for the development of treatment stimuli. As such, they were not assessed for the outcome measure. |
Arm/Group Title | SFA Treatment Participants |
---|---|
Arm/Group Description | Stroke survivors received Semantic Feature Analysis for the treatment of word-retrieval deficits. Each SFA treatment participant received word-retrieval therapy applied sequentially to experimental lists of items. Effect sizes were calculated for each participant for each list. An average effect size was calculated for each participant and an overall average was determined for all participants as a group. |
Measure Participants | 13 |
Measure participant effect sizes | 68 |
Mean (Standard Deviation) [d-index (effect size)] |
7.15
(3.1)
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | SFA Treatment Participants |
---|---|---|
Comments | Effect sizes were calculated - this is a comparison of perfomance in baseline (repeated measurements prior to treatment) relative to peformance following treatment | |
Type of Statistical Test | Superiority or Other | |
Comments | ||
Statistical Test of Hypothesis | p-Value | |
Comments | ||
Method | ||
Comments | ||
Method of Estimation | Estimation Parameter | effect size |
Estimated Value | 7.15 | |
Confidence Interval |
(2-Sided) % to |
|
Parameter Dispersion |
Type: Standard Deviation Value: 3.1 |
|
Estimation Comments | the reported effect size is a d-index value |
Adverse Events
Time Frame | 3 years | |||
---|---|---|---|---|
Adverse Event Reporting Description | ||||
Arm/Group Title | SFA Treatment Participants | NonTreatment Stimuli Development Participants | ||
Arm/Group Description | Stroke-survivors who received Semantic Feature Analysis therapy for aphasic word-retrieval deficits Semantic Feature Training: The treatment is designed to stimulate the semantic feature network so that it may serve as not only a mechanism for improving disrupted lexical semantic processing, but also as a compensatory strategy during word retrieval failures. | Non-brain-injured participants who were utilized to develop treatment stimuli. | ||
All Cause Mortality |
||||
SFA Treatment Participants | NonTreatment Stimuli Development Participants | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | / (NaN) | / (NaN) | ||
Serious Adverse Events |
||||
SFA Treatment Participants | NonTreatment Stimuli Development Participants | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/16 (0%) | 0/94 (0%) | ||
Other (Not Including Serious) Adverse Events |
||||
SFA Treatment Participants | NonTreatment Stimuli Development Participants | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/16 (0%) | 0/94 (0%) |
Limitations/Caveats
More Information
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Dr. Julie Wambaugh |
---|---|
Organization | VA Salt Lake City Health Care System |
Phone | 801-582-1565 ext 1363 |
julie.wambaugh@health.utah.edu |
- C3826-R